Page last updated: 2024-12-10

mannotetraose

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

mannotetraose: RN given refers to cpd with ((1-3)linkage alpha-D-mannopyranose)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

beta-D-Manp-(1->4)-beta-D-Manp-(1->4)-beta-D-Manp-(1->4)-D-Manp : A tetrasaccharide comprised of four D-mannose residues connected by beta(1->4) linkages. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

mannotetraose : Any tetrasaccharide composed of 4 mannose moieties. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID53477669
CHEBI ID62973
MeSH IDM0119165

Synonyms (7)

Synonym
mannotetraose
CHEBI:62973
beta-d-manp-(1->4)-beta-d-manp-(1->4)-beta-d-manp-(1->4)-d-manp
beta-d-mannopyranosyl-(1->4)-beta-d-mannopyranosyl-(1->4)-beta-d-mannopyranosyl-(1->4)-d-mannopyranose
mannose, o-beta-d-mannopyranosyl-(1-4)-o-beta-d-mannopyranosyl-(1-4)-o-beta-d-mannopyranosyl-(1-4)-, d-
d-mannose, o-beta-d-mannopyranosyl-(1-4)-o-beta-d-mannopyranosyl-(1-4)-o-beta-d-mannopyranosyl-(1-4)-
Q27132313
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
mannotetraoseAny tetrasaccharide composed of 4 mannose moieties.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (12.50)18.7374
1990's3 (18.75)18.2507
2000's3 (18.75)29.6817
2010's8 (50.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]